Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
19/08/2022 18:01
Aug 19 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* POSTPONES QUARTERLY REPORT FOR Q2 2022
* BOARD OF DIRECTORS OF DANCANN PHARMA HAS DECIDED TO
POSTPONE
REPORT FOR Q2 UNTIL WEDNESDAY, AUGUST 31, 2022
Source text for Eikon: ID:nWkr3WLMdS
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874